Filter
2184
Filtered Results: 2184
Text search:
drug-resistant
TB
Featured
Recommendations
219
New Publications
625
Language
Document type
No document type
1442
Studies & Reports
251
Guidelines
238
Manuals
74
Strategic & Response Plan
60
Situation Updates
44
Fact sheets
34
Training Material
27
Infographics
8
Online Courses
3
Brochures
2
Videos
1
Countries / Regions
India
126
Kenya
73
Western and Central Europe
71
South Africa
71
Eastern Europe
50
Nepal
49
Tanzania
47
Ethiopia
46
Uganda
42
Zambia
37
Nigeria
36
Global
36
Malawi
32
Sierra Leone
31
Liberia
31
Myanmar / Burma
31
Namibia
30
Ghana
29
Africa
29
Rwanda
26
Latin America and the Carribbean
26
Bangladesh
26
Lesotho
24
Cambodia
24
Asia
23
Ukraine
20
Philippines
18
South–East Asia Region
16
Indonesia
16
Zimbabwe
15
Russia
14
Botswana
14
Colombia
12
Senegal
12
Mozambique
11
Eswatini/ Swaziland
9
Pakistan
9
Tajikistan
8
Germany
8
Argentina
8
Cameroon
7
Albania
7
Venezuela
7
Congo, Democratic Republic of
7
West and Central Africa
7
East and Southern Africa
7
Burkina Faso
6
Haiti
6
Middle East and North Africa
6
Thailand
5
Peru
5
Armenia
5
Brazil
5
Georgia
5
El Salvador
4
Syria
4
Laos
4
Eastern Europe and Central Asia
4
Paraguay
4
Vietnam
4
Sudan
4
South Sudan
4
North Macedonia
3
Timor Leste/ East Timor
3
Benin
3
Estonia
3
Guinea
3
Western Pacific Region
3
Uruguay
3
Bolivia
3
Moldova
3
Sri Lanka
3
Iran
2
Afghanistan
2
Morocco
2
USA
2
Jordan
2
Lebanon
2
Papua New Guinea
2
Romania
2
Bhutan
2
Ecuador
2
Madagascar
2
North Korea
1
Switzerland
1
Mexico
1
Gambia
1
Chile
1
Bulgaria
1
Guinea-Bissau
1
Hungary
1
Saudi Arabia
1
North America
1
Gabon
1
Turkmenistan
1
Maldives
1
Tunisia
1
Spain
1
Southern Africa
1
Nicaragua
1
Yemen
1
Greece
1
Central African Republic
1
Poland
1
Honduras
1
Angola
1
Iraq
1
Somalia
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
906
Clinical Guidelines
190
Public Health
69
Women & Child Health
40
Key Resources
31
Capacity Building
29
Pharmacy & Technologies
22
Annual Report MEDBOX
1
Toolboxes
TB
657
HIV
282
AMR
181
Pharmacy
50
NTDs
39
COVID-19
37
Ebola
28
Caregiver
28
Refugee
24
Global Health Education
23
Mental Health
19
Conflict
18
Polio
18
Rapid Response
15
Planetary Health
15
NCDs
13
Health Financing Toolbox
10
Disability
6
Natural Hazards
5
Cholera
3
Specific Hazards
2
Social Ethics
2
Zika
1
Tuberculosis MDR-TB & XDR-TB The 2008 Report
Technical information note. Ensuring an uninterrupted supply of quality-assured, affordable anti-TB
drugs and diagnostics to the world
This training toolkit by the European Laboratory Initiative for TB, HIV and Viral Hepatitis provides a unique combination of practical guidance and expert advice on the interpretation of selected WHO-endorsed tests for drug-resistant tuberculosis (DR-TB).
12 countries have a high TB estimated burden with an incidence rate more than 45 per 100 000 population They represent 88 of the cases in the Region
In 2019 the TB case detection gap in the Region was 52 500 cases
This guide provides practical, step-by-step guidance on how to organize, implement, and monitor community-based care for DR TB. It is equally useful for program planning or supervision. The target audience for this guide is TB Program Managers, governments, policy makers, nongovernmental organizatio...
Training for staff working at DR-TB management centres.
Training modules
Preventing tuberculosis infection from progressing to tuberculosis disease is a crucial component of the goal to eliminate tuberculosis. When deciding on the use of tuberculosis preventive therapy among household contacts, policy makers regularly ask questions, such as whether tuberculosis preventiv...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on...
This document provides practical guidance on planning and implementing next-generation sequencing (NGS) technology for characterization of Mycobacterium tuberculosis complex (MTBC) bacteria. The aim is to detect mutations associated with drug resistance in the context of a surveillance system for tu...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
